Victor Cervera-Carrascon was awarded with the EFIS-Biolegend Bright Sparks Award for his presentation entitled “Broad tumor microenvironment remodelling after Oncolytic Adenovirus coding for TNFa and IL-2 enables T-cell therapies to deliver complete responses in solid tumors” at European Congress of Immunology in Amsterdamin September 2018.
